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Summary Secretory breast carcinoma (SBC) is a rare type of invasive breast cancer.
Since little is known about the biology of this rare tumour, it is useful to report every
such case, in order to make as much information as possible available in the medical
literature. We present the case of an 18-year-old woman with a SBC treated by
mastectomy (Madden) and axillary node dissection (stage pT3N1M0)1 followed by
chemotherapy (FEC2 regimen) and radiotherapy. The patient has meanwhile
completed 4 years of follow-up with no evidence of recurrence. The authors review
the literature and summarize relevant findings concerning definition, pathology,
clinical picture, treatment, and follow-up.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
More than 95% of breast malignancies arise from
the epithelial elements of the breast and are
therefore carcinomas. Breast carcinomas can be
divided into two major groups: (1) carcinoma in
situ, in which the tumour cells remain confined to
the ducts; and (2) infiltrating carcinoma, whose
tumour cells invade the breast stroma and there-
fore, have the potential to metastasize.
SBC is an extremely rare type of breast cancer,
accounting for less than 1% of all infiltrating breast
carcinomas. It was originally termed ‘juvenile
breast cancer’ by McDivitt and Stewart in 1966,
because the only known patients were children or
very young women.1–3 However, subsequent studies
have included many adult patients, including a
substantial number of postmenopausal women, so
much so that approximately two-thirds of the
almost 100 published cases have been in adults.
Consequently, the term juvenile breast cancer has
been replaced by the more descriptive ‘secretory
breast cancer’ (SBC).3,4
The tumour can occur anywhere in the breast. It
frequently presents as a mobile, well-circum-
scribed, subareolar mass, sometimes simulating
fibroadenoma.3,5
Although it is well circumscribed macroscopi-
cally, there may be foci of invasion in the
surrounding breast tissue and associated ductal
carcinoma in situ (DCIS), which can be responsible
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for local recurrence after incomplete excision.3,4
Three histological patterns are seen, in varying
combinations: tubular, compact and honeycomb.3
The tumour is typically composed of cells with
abundant granular eosinophilic cytoplasm arranged
around small gland-like spaces. The spaces and the
cells themselves contain recognizable material.1
When studied microscopically, SBC proves to be a
variant of invasive ductal carcinoma with unusual
structural features.4
There is no known hormonal abnormality that
would explain the prominent secretory activity in
this type of carcinoma. It is normally negative for
oestrogen and progesterone receptors.4
It is necessary to perform a surgical biopsy to
establish the diagnosis of SBC, but the lesion is
sometimes suspected on examination of an aspira-
tion cytology specimen.4,6
Case report
The authors present the case of a 18-year-old
woman resident in Portugal, who had been followed
in the surgical unit of her local hospital from the
age of 15 for an occasional brownish discharge from
the left nipple. At the time of her first presentation
she had undergone mammary echography, which
documented cystic formation with a probable
intracystic papilloma, galactography, which showed
a normal picture, cytological investigation (nega-
tive) and bacteriological examination of the ma-
millary discharge (negative), and removal of an
aspiration cytology specimen, which proved to be
compatible with fibrocystic disease. Some months
later galactography was repeated, showing: ‘‘yac-
centuated ductal ectasia in the main channels,
y[and] small nodular images especially in the
terminal ducts, suggesting intraductal papillomas.’’
All of this was consistent with a diagnosis of
juvenile papillomatosis.
Two years later the patient noted a nodule in the
inferior internal quadrant of the left mammary
gland. Examination of a biopsy taken from the
lesion revealed an infiltrating secretory carcinoma.
She was admitted to the local hospital for a left
modified radical mastectomy (Madden). Macro-
scopic examination of the operative specimen
revealed ‘‘ybreast with inverted nipple. (y) in
the subareolar area, there was observed a nodule
of circinated boards, 3 cm in diameter, white in
colour and of a firm consistency’’; the microscopic
findings confirmed a SBC (Fig. 1) measuring 5.5 cm
in its largest diameter. During axillary node dissec-
tion eight lymph nodes were isolated, one of which
contained metastases. There were no signs of
venous invasion; but there were visible subareolar
papillomatosis lesions. Examination for oestrogen
and progesterone receptors was negative. An
analysis for Her2/neu expression was not per-
formed.
The patient received adjuvant chemotherapy
with 5-FU 500mg/m2 i.v. on day 1, epirubicin
75mg/m2 i.v. on day 1 and cyclophosphamide
500mg/m2 i.v. on day 1 of each 3-week cycle for
six cycles, after which she underwent radiotherapy,
whole breast and drainage chains, with a total dose
of 50Gy.
After completing a 4-year follow-up with no
evidence of local or distant recurrence, the patient
went on reconstructive surgery, with an excellent
cosmetic outcome.
Discussion
Surgery is still considered the most appropriate
treatment for primary SBC.1,3 There is some degree
of consensus about the extent of surgery, as the
principal management problems are late local
chest wall recurrence and regional axillary lymph
node spread.3 Whenever possible, prepubertal girls
should be treated initially by wide local excision.
Preservation of the breast bud should be at-
tempted, but this is not always possible, so that
breast development can be impaired. Breast tissue
peripheral to the tumour should be sampled
generously and examined for intraductal foci, since
these can indicate an increased risk of local
recurrence. Mastectomy may be necessary in the
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Figure 1 Solid and acinar neoplastic structures with
abundant luminal secretion.
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case of large primary tumours or to control
recurrent disease in the breast.4 Axillary dissection
should be performed whenever the clinical findings
suggest nodal involvement, since late recurrence in
the chest wall and axillary lymph nodes is well
documented. It has been observed that nodal
metastases in children tend to be small and
undetectable in clinical examination.4
Of the cases reported thus far in the literature,
postoperative radiotherapy has been used in at least
two, as has adjuvant chemotherapy. There is too
little evidence to justify recommending either
approach over the other in the management of
primary SBC.3,4 Since systemic metastases are ex-
tremely rare, even in patients with axillary node
metastases, there is no evidence to suggest that
systemic adjuvant therapy would be beneficial for
such patients.3,4 SBC has an indolent nature and
appears to be nonresponsive to various chemotherapy
protocols.3
Some authors believe that local recurrence is
more likely to be the result of incomplete excision
than of inherent aggressiveness. Inadequate exci-
sion often results from a desire to preserve breast
tissue. Early wide local excision can ultimately
result in conservation of more breast tissue.4
However, there are several reports of late recur-
rences and distant metastases, indicating the need
for long-term follow-up of these patients.
SBC has a better prognosis than the more usual
form of ductal carcinoma.1 Tumour size is a strong
determinant of outcome: tumours under 2 cm have
not usually recurred.5 Other features that ensure
an excellent prognosis include young age and the
absence of stromal invasion at the periphery of the
lesion.7
Recently, three cases of a new SBC entity, acinic
cell-like breast carcinoma, were reported. They
were typical of SBC, and were clinically, histologi-
cally and immunohistochemically analogous to
acinic cell carcinoma of the salivary gland; prob-
ably they are identical lesions.8
Conclusion
The current case illustrates an unusual presenta-
tion of this rare type of breast carcinoma: a large
lesion with lymph node involvement at the time of
mastectomy and none of the clinicopathological
findings that are thought to confer a good prog-
nosis. This was crucial in our decision on adjuvant
treatment despite the tumour’s biological indo-
lence.
Earlier publications on such tumours include few
papers that specify the type of chemotherapy and
radiotherapy given, when applicable, and results
obtained with these. Like Herz et al.,3 we too think
that it is useful to report every case of this rare
tumour, in order to pool as much information as
possible about its biology.
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